Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours

Area of Science:

• Pharmacology
• Immunology
• Oncology

Background:

• Flavone 8-acetic acid (FAA) is a novel anticancer agent in clinical trials.
• Its unique properties differ from conventional cytotoxic drugs, especially in solid murine tumors.
• Novel mechanisms of action for FAA are under investigation.

Purpose of the Study:

• To review and categorize the proposed mechanisms of action for Flavone 8-acetic acid (FAA).
• To evaluate the evidence supporting direct cytotoxicity, biologic response modification, and pharmacologic effects of FAA.
• To understand the unique anticancer activity spectrum of FAA.

Main Methods:

• Literature review summarizing evidence for proposed FAA mechanisms.
• Analysis of in vitro and in vivo cytotoxicity data.
• Assessment of FAA's effects on immune cells (NK cells, interferon alpha) and synergistic potential with IL-2.
• Evaluation of FAA's impact on tumor blood flow.

Main Results:

• FAA exhibits cytotoxicity to tumor cells in vitro, but requires high concentrations and prolonged exposure.
• In vivo, FAA is significantly more cytotoxic, suggesting mechanisms beyond direct action.
• FAA stimulates NK cell activity, induces interferon alpha, and synergizes with IL-2 in murine renal cancer models.
• FAA dramatically reduces tumor blood flow, potentially creating conditions for reactive chemistry.

Conclusions:

• Direct cytotoxicity alone is unlikely to explain FAA's in vivo efficacy.
• While FAA modulates immune responses, a definitive link to antitumor activity requires confirmation.
• Reduced tumor blood flow is a key, unusual property of FAA.
• A combination of direct cytotoxicity, immunomodulation, and pharmacologic effects likely contributes to FAA's anticancer activity.